Drägerwerk AG & Co. KGaA (FRA:DRW8)
Market Cap | 1.02B |
Revenue (ttm) | 3.37B |
Net Income (ttm) | 115.24M |
Shares Out | n/a |
EPS (ttm) | n/a |
PE Ratio | 8.86 |
Forward PE | n/a |
Dividend | 1.97 (4.05%) |
Ex-Dividend Date | May 12, 2025 |
Volume | 6 |
Average Volume | 50 |
Open | 49.30 |
Previous Close | 48.70 |
Day's Range | 49.30 - 49.30 |
52-Week Range | 39.10 - 55.80 |
Beta | n/a |
RSI | 48.35 |
Earnings Date | Jul 29, 2025 |
About Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departmen... [Read more]
Financial Performance
In 2024, Drägerwerk AG & Co. KGaA's revenue was 3.37 billion, a decrease of -0.08% compared to the previous year's 3.37 billion. Earnings were 124.41 million, an increase of 12.65%.
Financial StatementsNews

Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Q1 2025 Results Conference Call April 30, 2025 8:00 AM ET Company Participants Nikolaus Hammerschmidt - IR Tom Fischler - IR Stefan Dräger - Chief Executive Offic...

Drägerwerk Sees Strong Q1 2025 Demand Surge
Drägerwerk AG & Co. KGaA kicked off 2025 with a robust performance, marked by a surge in order intake and a promising outlook for the year. With orders soaring to EUR 861 million, the company outpaced...

EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Quarter Results/Forecast Drägerwerk AG & Co. KGaA: Dräger with strong demand in the first quarter of 2025 30.04.2025 / 07:30 CET/CEST The issuer is so...

Drägerwerk's Q1 2025 EBIT Dips, But Strong Orders Keep Forecast Bright
Drägerwerk's Q1 2025 financials show a notable EBIT decline, yet a surge in orders hints at resilience, setting the stage for anticipated growth in the coming year. Jetzt den vollständigen Artikel les...

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order development
EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2025: EBIT below prior year – forecast confirmed due to good order dev...

EQS-AGM: Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-News: Drägerwerk AG & Co. KGaA / Announcement of the Convening of the General Meeting Drägerwerk AG & Co. KGaA: Announcement of the Convening of the General Meeting in Lübeck on 09.05.2025 accordi...
Drägerwerk AG & Co. KGaA GAAP EPS of €6.61, revenue of €3.37B

Drägerwerk AG & Co KGaA (DGWPF) Full Year 2024 Earnings Call Transcript
Drägerwerk AG & Co KGaA (OTCPK:DGWPF) Full Year 2024 Earnings Conference Call March 31, 2025 9:00 AM ET Company Participants Stefan Dräger – Chief Executive Officer Gert-Hartwig Lescow – Chief Financi...
Drägerwerk AG & Co. KGaA 2024 Q4 - Results - Earnings Call Presentation

Drägerwerk: 2024 Profit Surge & Dividend Boost!
Drägerwerk AG & Co. KGaA shines with robust financial growth in 2024, boosting dividends and setting ambitious targets for the future. Jetzt den vollständigen Artikel lesen

EQS-News: Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Annual Report/Dividend Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend 31.03.2025 / 07:30 CET/CEST The i...

EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final notice
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014: Purchase of own shares – final...

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecast 2025
EQS-Ad-hoc: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results/Forecast Drägerwerk AG & Co. KGaA: Preliminary figures 2024: Net sales just below and earnings just above expectations – Forecas...

EQS-News: Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel Drägerwerk AG & Co. KGaA: Changes in the chair of the Dräger Supervisory Board 11.12.2024 / 14:06 CET/CEST The issuer is solely responsible ...